Business Description
Chularat Hospital PCL
ISIN : TH4539010Z03
Compare
Compare
Traded in other countries / regions
CHG.Thailand IPO Date
2013-05-16Description
Chularat Hospital PCL operates hospitals and clinics in Thailand. The company operates through several branches of clinics and hospitals. Additionally, it distributed medical instruments and dietary supplements to customers in Thailand. The Group have two reportable segments that are hospital operations and other businesses that support hospital business including distribution of medical instruments. A majority of the company's revenue is derived from hospital operations, consisting of medical fees, medicine sales, and hospital room sales.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.87 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | 0.41 | |||||
| Interest Coverage | 57.54 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 10.34 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.5 | |||||
| 3-Year EBITDA Growth Rate | 7.5 | |||||
| 3-Year EPS without NRI Growth Rate | 5.9 | |||||
| 3-Year FCF Growth Rate | -1.5 | |||||
| 3-Year Book Growth Rate | 23.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 10.11 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.71 | |||||
| 9-Day RSI | 41.36 | |||||
| 14-Day RSI | 41.75 | |||||
| 6-1 Month Momentum % | -4.52 | |||||
| 12-1 Month Momentum % | -16.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.72 | |||||
| Quick Ratio | 2.5 | |||||
| Cash Ratio | 0.94 | |||||
| Days Inventory | 19.38 | |||||
| Days Sales Outstanding | 37.81 | |||||
| Days Payable | 46.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.28 | |||||
| Dividend Payout Ratio | 0.99 | |||||
| 3-Year Dividend Growth Rate | 23.9 | |||||
| Forward Dividend Yield % | 3.45 | |||||
| 5-Year Yield-on-Cost % | 14.71 | |||||
| Shareholder Yield % | 3.43 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.97 | |||||
| Operating Margin % | 17.87 | |||||
| Net Margin % | 13.53 | |||||
| FCF Margin % | 12.31 | |||||
| ROE % | 14.06 | |||||
| ROA % | 10.26 | |||||
| ROIC % | 14.64 | |||||
| ROC (Joel Greenblatt) % | 26.1 | |||||
| ROCE % | 16 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.79 | |||||
| Forward PE Ratio | 26.39 | |||||
| PE Ratio without NRI | 29.79 | |||||
| Shiller PE Ratio | 22.52 | |||||
| Price-to-Owner-Earnings | 20.87 | |||||
| PEG Ratio | 1.24 | |||||
| PS Ratio | 4.07 | |||||
| PB Ratio | 4.18 | |||||
| Price-to-Tangible-Book | 4.27 | |||||
| Price-to-Free-Cash-Flow | 32.87 | |||||
| Price-to-Operating-Cash-Flow | 15.14 | |||||
| EV-to-EBIT | 22.48 | |||||
| EV-to-Forward-EBIT | 19.51 | |||||
| EV-to-EBITDA | 17.02 | |||||
| EV-to-Forward-EBITDA | 14.3 | |||||
| EV-to-Revenue | 3.98 | |||||
| EV-to-Forward-Revenue | 3.47 | |||||
| EV-to-FCF | 32.6 | |||||
| Price-to-Projected-FCF | 1.3 | |||||
| Price-to-DCF (Earnings Based) | 1.07 | |||||
| Price-to-DCF (FCF Based) | 1.05 | |||||
| Price-to-Median-PS-Value | 0.7 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.19 | |||||
| Price-to-Graham-Number | 2.38 | |||||
| Price-to-Net-Current-Asset-Value | 23.83 | |||||
| Earnings Yield (Greenblatt) % | 4.45 | |||||
| FCF Yield % | 3.02 | |||||
| Forward Rate of Return (Yacktman) % | 24.49 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers